Cited by 212Hippo pathway signaling and YAP/TAZPI3K/AKT/mTOR signaling in cancerAmino Acid Enzymes and Metabolism

The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1

Open access
Hansen, Carsten Gram, Ng, Yuen Lam Dora, Lam, Wai-Ling Macrina, Plouffe, Steven W, Guan, Kun-Liang·2015·Cell Research

Abstract

YAP and TAZ are transcriptional co-activators and function as the major effectors of the Hippo tumor suppressor pathway, which controls cell growth, tissue homeostasis, and organ size. Here we show that YAP/TAZ play an essential role in amino acid-induced mTORC1 activation, particularly under nutrient-limiting conditions. Mechanistically, YAP/TAZ act via the TEAD transcription factors to induce expression of the high-affinity leucine transporter LAT1, which is a heterodimeric complex of SLC7A5 and SLC3A2. Deletion of YAP/TAZ abolishes expression of LAT1 and reduces leucine uptake. Re-expression of SLC7A5 in YAP/TAZ knockout cells restores leucine uptake and mTORC1 activation. Moreover, SLC7A5 knockout cells phenocopies YAP/TAZ knockout cells which exhibit defective mTORC1 activation in response to amino acids. We further demonstrate that YAP/TAZ act through SLC7A5 to provide cells with a competitive growth advantage. Our study provides molecular insight into the mechanism of YAP/TAZ target genes in cell growth regulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cr.2015.140

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SLC3A2 expression remained unaffected by YAP/TAZ knockdown.

    “Notably, the expression of its partner protein solute carrier family 3 member 2 (SLC3A2), which forms a heterodimer with SLC7A5 to facilitate leucine transport and mTORC1 activation (49), remained unaffected (Figure 6B).”

    From YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axis (2024) · cites this paper as [49]

    In “YAP and TAZ regulate leucine uptake via SLC7A5” (page unavailable), the paper reports that YAP/TAZ double-knockout cells had reduced SLC3A2 protein expression and that re-expressing YAP restored it. This is contrary to the stated claim that SLC3A2 expression was unaffected, although the paper tested knockout rather than knockdown. (LLM, conf=0.85)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • YAP/TAZ increase the expression of genes that encode the leucine transporter LAT1.

    “YAP/TAZ also increase the expression of genes that encode the leucine transporter LAT1 (52)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hansen, C. G., Ng, Y. L. D., Lam, W.-L. M., Plouffe, S. W., & Guan, K.-L.
Affiliations
University of California San Diego (US)
Corresponding author
Guan, Kun-Liang
Venue
Cell Research
Published
2015-11-27
Volume
25
Issue
12
Pages
1299-1313
ISSN
  • 1001-0602 (ISSN-L)
  • 1748-7838
OpenAlex
W2180757710
Cited by
212
References
60
Citations by year
2026: 15 · 2025: 24 · 2024: 25 · 2023: 19 · 2022: 17 · 2021: 22 · 2020: 26 · 2019: 18 · 2018: 21 · 2017: 17 · 2016: 8
FWCI
8.17
Type
journal article
Language
en
Open access
Locations
  • Cell Research (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Danmarks Frie Forskningsfond
  • National Institutes of Health (CA132809)
  • University of California, San Diego (T32 GM007752)
  • National Eye Institute (R01EY022611, EY0226116)
  • National Cancer Institute (R35CA196878, CA132809, R01CA108941, R01CA132809)
  • National Institute of General Medical Sciences (T32GM007752)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
Hippo signaling pathway, YAP, TAZ, mTORC1, amino acid signaling, leucine uptake, LAT1, SLC7A5, SLC3A2, TEAD transcription factors, nutrient limitation, cell growth regulation, transcriptional coactivator
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Hippo Signaling Pathway, YAP-Signaling Proteins, Transcriptional Coactivator with PDZ-Binding Motif Proteins, Amino Acids, Cells, Cultured, Humans, Phosphoproteins, Transcription Factors, Signal Transduction, Trans-Activators, Protein Serine-Threonine Kinases, Multiprotein Complexes, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Cell Proliferation, HEK293 Cells, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review